IRIDEX Corporation

IRIX ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2016 FY2015 FY2013 FY2012 FY2011 FY2010
Revenue $46.2M $42.8M $38.3M $33.9M $33.2M $31.0M
Cost of Revenue $25.3M $21.4M $19.7M $17.5M $16.9M $15.6M
Gross Profit $20.8M $21.4M $18.6M $16.3M $16.3M $15.4M
Gross Margin 45.1% 50.0% 48.6% 48.3% 49.1% 49.8%
Operating Expenses
Research & Development $5.4M $4.6M $3.7M $4.4M $3.9M $3.3M
SG&A Expense $7.6M $6.0M $5.0M $4.9M $4.3M $4.3M
Operating Income $-2.6M $2.6M $2.6M $-860.0K $1.9M $1.2M
Operating Margin -5.6% 6.0% 6.9% -2.5% 5.8% 4.0%
Interest Expense — — — — — —
Pretax Income $-2.7M $1.3M $2.3M $-270.0K $2.4M $1.8M
Income Tax Expense $9.1M $-8.7M $31.0K $-100.0K $297.0K $262.0K
Net Income $-11.7M $10.0M $2.2M $1.4M $2.6M $2.6M
Net Margin -25.4% 23.4% 5.8% 4.2% 7.9% 8.3%
EPS (Basic) $-1.15 $1.01 $0.24 $0.16 $0.29 $0.17
EPS (Diluted) $-1.15 $0.97 $0.22 $0.16 $0.26 $0.16
Shares Outstanding (Basic) 10.2M 9.9M 9.2M 8.9M 9.0M 8.8M
Shares Outstanding (Diluted) 10.2M 10.4M 10.1M 8.9M 10.2M 9.9M
Dividends Per Share — — — — — —
← Newer Page 2 of 2 Older →